1 recruiting, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Terminated 1 |
Follow ANCA Associated Vasculitis: new trials by email Literature Review of ANCA Associated Vasculitis trials Research Report on ANCA Associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM) Telitacicept, Placebo of Telitacicept - ANCA Associated Vasculitis | Phase 4 | Recruiting | Chinese SLE Treatment And Research Group | 40 | 2023-06-29 | 2023-07-27 |
| Hydroxychloroquine in ANCA Vasculitis Evaluation Hydroxychloroquine, Placebo - ANCA Associated Vasculitis, Microscopic Polyangiitis | Phase 4 | Terminated | Guy's and St Thomas' NHS Foundation Trust | 43 | 2020-12-17 | 2026-04-29 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Churg-Strauss Syndrome (1) · Granulomatosis with Polyangiitis (1) · Microscopic Polyangiitis (1)
Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Systemic Vasculitis (2) · Vascular Diseases (2) · Vasculitis (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Granuloma (1) · Hemic and Lymphatic Diseases (1)
Hydroxychloroquine (1) · telitacicept (1)
Chinese SLE Treatment And Research Group (1) · Guy's and St Thomas' NHS Foundation Trust (1)
China (1) · United Kingdom (1)
David D'Cruz (1) · Jing Li, MD (1)
2018 (1)